| Income Statement |
| Operating Expenses | 106.58M |
|
| Research and Development Expense | 103.92M |
| Selling, General and Administrative Expense | 2.49M |
| Operating Income | -106.58M |
| Net Income | -97.54M |
| Net Income Common Stock | -97.54M |
| Net Income Common Stock (USD) | -97.54M |
| Consolidated Income | -97.54M |
| Earnings per Basic Share | -0.78 |
| Earnings per Basic Share (USD) | -0.78 |
| Earnings per Diluted Share | -0.78 |
| Earning Before Interest & Taxes (EBIT) | -97.54M |
| Earning Before Interest & Taxes (USD) | -97.54M |
| Weighted Average Shares | 125.09M |
| Weighted Average Shares Diluted | 125.09M |
| Balance Sheet |
| Cash and Equivalents | 650.03M |
| Cash and Equivalents (USD) | 650.03M |
| Trade and Non-Trade Receivables | 3.27M |
| Current Assets | 599.40M |
| Property, Plant & Equipment Net | 113.24M |
| Total Assets | 773.54M |
| Debt Current | 875.00K |
| Total Debt | 3.65M |
| Current Liabilities | 48.59M |
| Debt Non-Current | 2.77M |
| Total Liabilities | 53.69M |
| Accumulated Retained Earnings (Deficit) | -841.74M |
| Shareholders Equity | 719.85M |
| Shareholders Equity (USD) | 719.85M |
| Assets Non-Current | 174.14M |
| Total Debt (USD) | 3.65M |
| Liabilities Non-Current | 5.10M |
| Trade and Non-Trade Payables | 46.72M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 163.00K |
| Net Cash Flow from Financing | -43.00K |
| Net Cash Flow / Change in Cash & Cash Equivalents | -93.90M |
| Capital Expenditure | -12.91M |
| Issuance (Repayment) of Debt Securities | -43.00K |
| Net Cash Flow from Investing | -12.91M |
| Net Cash Flow from Operations | -80.95M |
| Effect of Exchange Rate Changes on Cash | -8.00K |
| Share Based Compensation | 1.22M |